Comparative study of two drugs(Dinoprostone gel and mifepristone)for labour pain stimulatio

Phase 2

• Conditions: Health Condition 1: O630- Prolonged first stage (of labor)

• Registration Number: CTRI/2022/09/045885
• Lead Sponsor: Dr P Srirohini

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Willing to participate

2. Primigravida

3. Singleton pregnancy,Cephalic presentation.

4. Gestational age 40+ weeks.

5. Maternal age >19years

6. No contraindications for prostaglandins or mifepristone.

7. No contraindication for vaginal delivery

8. Modified Bishopââ?¬•s Score < 6

9. Intact membranes.

10.Women with history of 1 or 2 previous abortions.

Exclusion Criteria

Breech presentation

Cephalopelvic disproportion

History of 3 or more abortions

Estimated fetal weight > 4.5 kg or < 2kg

Multigravida,Twin pregnancy

Obstetric complications like Diabetes ,Abruptio placenta or Placenta previa.

Abnormal fetal heart rate patterns.

Premature rupture of membranes.

Active genital infection.

Contraindication for mifepristone

Chorioamnionitis

Myoma or uterine anomalies

IUDââ?¬•S

IVF Conception

Study & Design

• Study Type: Interventional
• Study Design: Not specified